Targeting of Nrf2 improves antitumoral responses by human NK cells, TIL and CAR T cells during oxidative stress

• Andreas Lundqvist,
• Rolf Kiessling,
• Isabelle Magalhaes,
• Jonas Mattsson,
• Stefanie Renken,
• Takahiro Nakajima,
• Elias S J Arnér,
• Stina Linnea Wickström

Affiliations

Andreas Lundqvist

Aff1 grid.4714.60000000419370626Karolinska Institutet Stockholm Sweden

Rolf Kiessling

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

Isabelle Magalhaes

Aff144 grid.4714.60000000419370626Karolinska Institutet Stockholm Stockholms Lan Sweden

Jonas Mattsson

Aff144 grid.4714.60000000419370626Karolinska Institutet Stockholm Stockholms Lan Sweden

Stefanie Renken

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

Takahiro Nakajima

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

Elias S J Arnér

Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

Stina Linnea Wickström

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden